Viewing Study NCT00070304


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-02-08 @ 12:42 AM
Study NCT ID: NCT00070304
Status: COMPLETED
Last Update Posted: 2013-07-26
First Post: 2003-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
Sponsor: Children's Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: AHOD0321
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View